Foresite Capital Management VI LLC

Foresite Capital Management VI LLC reported 22 holdings worth US$566M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Foresite Capital Management VI LLC reported 22 holdings worth US$566M as of Sep 30, 2026. Largest: CG Oncology, Inc., Latigo Biotherapeutics, Inc. and Seaport Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
22
Value as reported
US$566M

The filing in full

CompanySharesValue as reported% of portfolio
CG Oncology, Inc.2.11MUS$150M26.4%
Latigo Biotherapeutics, Inc.2.2MUS$36.8M6.5%
Seaport Therapeutics, Inc.1.78MUS$35.9M6.3%
Denali Therapeutics Inc.1.62MUS$33.4M5.9%
Parabilis Medicines, Inc.999KUS$32.3M5.7%
Alumis Inc.4.25MUS$31.4M5.5%
Agios Pharmaceuticals, Inc.827KUS$27.5M4.9%
Verastem, Inc.3.15MUS$25.3M4.5%
Corvus Pharmaceuticals, Inc.1.83MUS$21.1M3.7%
Kymera Therapeutics, Inc.146KUS$16.4M2.9%
ArriVent BioPharma, Inc.490KUS$14.8M2.6%
Obsidian Therapeutics, Inc.916KUS$12.6M2.2%
Jade Biosciences, Inc.887KUS$12.5M2.2%
Hinge Health, Inc.108KUS$10.5M1.9%
Aura Biosciences, Inc.1.33MUS$8.37M1.5%
Beam Therapeutics Inc.330KUS$8.07M1.4%
Zura Bio Limited1.76MUS$7.31M1.3%
Minerva Neurosciences, Inc1.99MUS$6.65M1.2%
Disc Medicine, Inc.68,470US$4.48M0.79%
Kailera Therapeutics, Inc.0US$00.00%
Research Alliance Corporation III0US$00.00%
AtaiBeckley Inc.0US$00.00%
Celldex Therapeutics, Inc.0US$00.00%
Crinetics Pharmaceuticals, Inc.0US$00.00%

Source

Download original · View original at SEC

Related